HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Tian Selected Research

2,4-bis(2-acetoxybenzamido)benzoic acid (AB 50)

7/2017Characteristics of Good's Syndrome in China: A Systematic Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Tian Research Topics

Disease

70Neoplasms (Cancer)
09/2022 - 11/2004
18Infections
04/2022 - 03/2007
18Glioma (Gliomas)
06/2020 - 03/2002
16Inflammation (Inflammations)
02/2022 - 01/2007
14Hepatocellular Carcinoma (Hepatoma)
05/2022 - 12/2014
12Neoplasm Metastasis (Metastasis)
01/2022 - 01/2010
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2019
8Carcinogenesis
01/2022 - 04/2013
8Carcinoma (Carcinomatosis)
10/2021 - 12/2003
7Hypoxia (Hypoxemia)
09/2022 - 05/2013
7Wounds and Injuries (Trauma)
05/2022 - 03/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 01/2014
6COVID-19
03/2022 - 01/2020
5Lymphatic Metastasis
01/2022 - 06/2005
5Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2020
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 05/2013
5Trigeminal Neuralgia (Tic Douloureux)
01/2022 - 01/2016
5Adenocarcinoma
01/2022 - 05/2013
5Hemorrhage
11/2021 - 11/2013
4Lupus Nephritis
02/2022 - 01/2020
4Acute Kidney Injury (Acute Renal Failure)
01/2022 - 06/2020
4Fibrosis (Cirrhosis)
01/2022 - 01/2016
4Graft vs Host Disease (Graft-Versus-Host Disease)
06/2021 - 10/2016
4Reperfusion Injury
01/2021 - 01/2017
4Ischemia
01/2020 - 02/2012
4Autoimmune Diseases (Autoimmune Disease)
01/2020 - 04/2013
4Glioblastoma (Glioblastoma Multiforme)
01/2019 - 06/2014
4Type 2 Diabetes Mellitus (MODY)
05/2018 - 05/2010
4Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 05/2013
4Non-alcoholic Fatty Liver Disease
01/2018 - 01/2016
3Necrosis
02/2022 - 02/2011
3Hemangioma (Angioma)
01/2022 - 01/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 02/2019
3Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2020
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2021
3Bacterial Infections (Bacterial Infection)
05/2021 - 04/2017
3Cholangiocarcinoma
01/2021 - 06/2013
3Gallstones (Gallstone)
08/2020 - 09/2015
3Ulcerative Colitis
10/2019 - 12/2017
3Aggressive Periodontitis (Periodontosis)
02/2016 - 02/2010
3Diverticulum
08/2015 - 01/2007
3Appendicitis
10/2014 - 08/2012
2Stroke (Strokes)
08/2022 - 07/2021
2Cicatrix (Scar)
07/2022 - 04/2014
2Cognitive Dysfunction
05/2022 - 03/2012
2Delirium
03/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
07/2022 - 05/2004
16Messenger RNA (mRNA)IBA
07/2022 - 03/2002
12MicroRNAs (MicroRNA)IBA
07/2022 - 08/2016
12Biological ProductsIBA
01/2022 - 12/2003
11Pharmaceutical PreparationsIBA
10/2021 - 04/2014
10Long Noncoding RNAIBA
10/2022 - 08/2016
10CytokinesIBA
01/2022 - 02/2011
9Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2017
8RNA (Ribonucleic Acid)IBA
01/2022 - 06/2016
7Metformin (Glucophage)FDA LinkGeneric
05/2022 - 12/2014
6Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2010
6CholesterolIBA
10/2020 - 09/2015
6Indicators and Reagents (Reagents)IBA
02/2019 - 04/2013
5Oxygen (Dioxygen)IBA
07/2022 - 03/2012
5CateninsIBA
05/2022 - 05/2016
5LipidsIBA
01/2020 - 01/2013
4Peptides (Polypeptides)IBA
01/2022 - 08/2011
4Antiviral Agents (Antivirals)IBA
01/2022 - 07/2016
4HMGB1 Protein (HMG1)IBA
11/2021 - 09/2018
4LigandsIBA
09/2021 - 03/2018
4MicellesIBA
10/2020 - 02/2015
4Temozolomide (Temodar)FDA LinkGeneric
06/2020 - 01/2016
3Immune Checkpoint InhibitorsIBA
09/2022 - 09/2021
3CreatinineIBA
04/2022 - 01/2022
3Circular RNAIBA
02/2022 - 01/2022
3Monoclonal AntibodiesIBA
02/2022 - 08/2015
3Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 06/2014
3Hormones (Hormone)IBA
01/2022 - 10/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2005
3GoldIBA
01/2022 - 07/2016
3Uric Acid (Urate)IBA
01/2022 - 06/2012
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 05/2017
3DNA (Deoxyribonucleic Acid)IBA
10/2021 - 10/2019
316S Ribosomal RNAIBA
01/2021 - 01/2016
3AcidsIBA
10/2020 - 01/2018
3SolutionsIBA
05/2020 - 01/2016
3EnzymesIBA
01/2020 - 06/2015
3AntibodiesIBA
01/2019 - 10/2013
3Fluorouracil (Carac)FDA LinkGeneric
04/2017 - 07/2016
3Arginine (L-Arginine)FDA Link
08/2016 - 02/2015
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2016 - 04/2013
2CollagenIBA
07/2022 - 01/2022
2AlbuminsIBA
04/2022 - 01/2021

Therapy/Procedure

26Therapeutics
01/2022 - 08/2007
9Immunotherapy
01/2022 - 01/2020
7Drug Therapy (Chemotherapy)
09/2022 - 04/2015
6Length of Stay
03/2022 - 01/2014
4Electrocoagulation (Electrocautery)
01/2022 - 01/2016
4Cholecystectomy
11/2021 - 12/2007
3Conversion to Open Surgery
01/2019 - 01/2009
3Laparoscopic Cholecystectomy
01/2019 - 01/2009
3Appendectomy
10/2014 - 01/2013
3Vaginal Hysterectomy
10/2014 - 08/2012
2Radiotherapy
04/2022 - 01/2020